寵物液態生物檢體市場規模、佔有率和成長分析：按產品、循環生物標記、技術、應用、最終用途和地區分類 - 2026-2033 年行業預測

2024年全球寵物液態生物檢體市場價值為2.456億美元，預計將從2025年的2.8367億美元成長到2033年的8.9839億美元。預測期（2026-2033年）的複合年成長率預計為15.5%。

全球寵物液態生物檢體市場分析顯示，受寵物飼養量增加和獸醫保健支出成長的推動，對非侵入性癌症診斷的需求日益成長。該市場主要由檢測腫瘤細胞遊離DNA的血液檢測主導，從而實現對伴侶動物的早期發現、分期和後續觀察。隨著飼主尋求與家人相同的先進治療方案，對創新診斷技術的需求也日益迫切。這個領域源自於人類腫瘤學，越來越多的公司正在開發適用於犬貓的檢測方法。專業診所的早期應用已證實了這些技術的臨床價值。此外，人工智慧技術透過將分子數據與細胞學數據相結合，增強了對低濃度腫瘤訊號的檢測能力，並提高了診斷準確性。這簡化了工作流程，促進了更廣泛地應用，從而改善了患者照護。

全球寵物液態生物檢體市場促進因素

人們對寵物癌症風險的日益關注，以及飼主主人對非侵入性診斷方案的強烈偏好，顯著提升了人們對液態生物檢體的興趣。獸醫專業人士高度重視這項技術，因為它有助於早期發現癌症，並在無需手術干預的情況下輔助治療決策。液態生物檢體滿足了這些需求，它提供了一種在最大限度減少動物壓力的同時，實現定期監測和檢體採集的方法。飼主的偏好與臨床評估的契合，推動了液態生物檢體服務的普及，擴大了市場潛力，並刺激了對相關技術創新和服務交付的投資。

全球寵物液態生物檢體市場面臨的限制因素

全球寵物液態生物檢體市場面臨許多限制因素，主要原因是高級獸醫診斷的保險保障不足以及報銷管道有限。這種情況導致寵物飼主自付費用增加，從而降低他們進行液態生物檢體的意願，最終影響獸醫診所的收入穩定性。缺乏完善的報銷機制會給客戶帶來經濟負擔，也可能使獸醫不願推薦此類診斷測試。此外，對於小規模的獸醫診所而言，投資必要技術的不確定性可能會阻礙液態生物檢體的常規應用，並影響市場的整體成長和永續性。

全球PET液態生物檢體市場趨勢

在全球寵物液態生物檢體市場，居家檢測正成為一種顯著趨勢，這主要源自於飼主對便利性和微創性檢測的需求。製造商正致力於開發簡化的檢體採集設備和易於理解的操作指南，以提高檢測依從性並加速疾病的早期發現。獸醫醫院和遠端醫療服務提供者正將這些居家檢測方案整合到其診療通訊協定中，以加強慢性疾病的管理，同時最大限度地減少寵物的壓力。這一趨勢不僅透過直接與寵物飼主互動擴大了市場進入，也支持了基於訂閱的服務模式，透過定期檢測和遠端結果解讀來建立持續的醫病關係。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球寵物液態生物檢體市場規模：按產品和複合年成長率分類（2026-2033 年）

• 消耗品
  • 試劑盒和試劑
  • 檢測和檢測組
• 裝置
• 軟體和服務

全球寵物液態生物檢體市場規模：按循環生物標記和複合年成長率分類（2026-2033 年）

• 循環性腫瘤細胞
• 循環腫瘤DNA
• 細胞中的遊離DNA
• 細胞外囊泡
• 其他生物標記

全球寵物液態生物檢體市場規模：按技術和複合年成長率分類（2026-2033 年）

• 多基因平行分析
• 單基因分析

全球寵物液態生物檢體市場規模：按應用及複合年成長率分類（2026-2033 年）

• 治療監測
• 預後和復發監測
• 治療方案
• 診斷和篩檢

全球寵物液態生物檢體市場規模：按最終用途和複合年成長率分類（2026-2033 年）

• 動物醫院
• 寵物診所
• 其他最終用戶

全球寵物液態生物檢體市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Fidoforce
• Vidium Animal Health
• Illumina
• Thermo Fisher Scientific
• Heska Corporation
• PetDx
• QIAGEN
• Volition
• Freenome Holdings
• Vethos
• Embark Veterinary
• One Health
• Ellie Diagnostics
• TGen
• MiDOG
• Basepaws
• Antech Diagnostics
• Pet-X
• AnimalBiome
• Exact Sciences Corporation

結論與建議

Global Pet Liquid Biopsy Market size was valued at USD 245.6 Million in 2024 and is poised to grow from USD 283.67 Million in 2025 to USD 898.39 Million by 2033, growing at a CAGR of 15.5% during the forecast period (2026-2033).

Market insights into the Global Pet Liquid Biopsy sector reveal an increasing demand for noninvasive cancer diagnostics, driven by the rise in pet ownership and veterinary expenditures. This market features blood-based assays that detect tumor-derived cell-free DNA, allowing for early detection, staging, and treatment monitoring of companion animals. As pet owners seek advanced treatment options akin to family care, the need for innovative diagnostics intensifies. The evolution of this field from human oncology has led to companies developing canine and feline assays, with early adopters in specialty clinics showcasing their clinical value. Furthermore, AI technologies enhance diagnostic accuracy by improving detection of low-abundance tumor signals and linking molecular data with cytology, streamlining workflows and stimulating broader adoption for enhanced patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pet Liquid Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pet Liquid Biopsy Market Segments Analysis

Global pet liquid biopsy market is segmented by product, circulating biomarkers, technology, application, end use and region. Based on product, the market is segmented into Consumables, Instruments and Software and Services. Based on circulating biomarkers, the market is segmented into Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA, Extracellular Vesicles and Other Biomarkers. Based on technology, the market is segmented into Multi-Gene Parallel Analysis and Single Gene Analysis. Based on application, the market is segmented into Treatment Monitoring, Prognosis and Recurrence Monitoring, Treatment Selection and Diagnosis and Screening. Based on end use, the market is segmented into Veterinary Hospitals, Pet Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pet Liquid Biopsy Market

The growing recognition of cancer risks in pets, coupled with a strong inclination among pet owners for less invasive diagnostic solutions, has significantly heightened interest in liquid biopsy testing. Veterinary professionals appreciate techniques that facilitate earlier detection and enhance treatment decision-making without the need for surgical interventions. Liquid biopsies fulfill these requirements by offering a means for routine monitoring and sample collection with minimal stress for the animals. This alignment of owner preferences with clinical endorsement paves the way for increased adoption of liquid biopsy services, expanding market potential and spurring investments in associated innovations and offerings.

Restraints in the Global Pet Liquid Biopsy Market

The Global Pet Liquid Biopsy market faces significant constraints due to inadequate insurance coverage and limited reimbursement options for advanced veterinary diagnostics. This situation leads to heightened out-of-pocket expenses for pet owners, deterring them from pursuing liquid biopsy tests and thereby affecting the revenue stability of veterinary clinics. The lack of established reimbursement frameworks can make veterinarians hesitant to recommend these diagnostic tests, as they may impose a financial strain on clients. Additionally, smaller veterinary practices may experience uncertainty about investing in the necessary technologies, hindering the routine use of liquid biopsies and obstructing the overall growth and sustainability of the market.

Market Trends of the Global Pet Liquid Biopsy Market

The Global Pet Liquid Biopsy market is witnessing a significant shift towards at-home testing, fueled by pet owners' desire for convenient and minimally invasive diagnostic options. Manufacturers are innovating simplified collection devices and straightforward instructions to facilitate compliance and promote early disease detection. Veterinary clinics and telemedicine providers are incorporating these home testing solutions into their care protocols, thereby enhancing chronic disease management while minimizing stress for pets. This trend not only expands market access by directly engaging pet owners but also supports subscription-based service models, fostering ongoing relationships through recurring testing and remote interpretation of results.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pet Liquid Biopsy Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Kits and Reagents
  • Assays and Panels
• Instruments
• Software and Services

Global Pet Liquid Biopsy Market Size by Circulating Biomarkers & CAGR (2026-2033)

• Market Overview
• Circulating Tumor Cells
• Circulating Tumor DNA
• Cell-Free DNA
• Extracellular Vesicles
• Other Biomarkers

Global Pet Liquid Biopsy Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Multi-Gene Parallel Analysis
• Single Gene Analysis

Global Pet Liquid Biopsy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Treatment Monitoring
• Prognosis and Recurrence Monitoring
• Treatment Selection
• Diagnosis and Screening

Global Pet Liquid Biopsy Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Pet Clinics
• Other End Users

Global Pet Liquid Biopsy Market Size & CAGR (2026-2033)

• North America (Product, Circulating Biomarkers, Technology, Application, End Use)
  • US
  • Canada
• Europe (Product, Circulating Biomarkers, Technology, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Circulating Biomarkers, Technology, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Circulating Biomarkers, Technology, Application, End Use)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Circulating Biomarkers, Technology, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Fidoforce
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vidium Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Freenome Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vethos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Embark Veterinary
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• One Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ellie Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiDOG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Basepaws
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antech Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pet-X
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AnimalBiome
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations